Skip to content
ClinCalc Pro
Menu
Gastroenterology Emergency Medicine Strong — international standard endoscopic classification; endorsed by BSG/ESGE/NICE

Forrest Classification of Upper GI Bleeding

Endoscopic classification system for upper GI bleeding lesions based on stigmata of recent haemorrhage. Guides re-bleeding risk and need for endoscopic therapy.

Used in: Gastrointestinal Bleeding

Score interpretation

Ia — Active Spurting — Re-bleed ~55% 1

Forrest Ia: active spurting haemorrhage. Rebleeding ~55% without endoscopic therapy (active bleeding, Laine 1994).

→ Immediate endoscopic haemostasis (clips, thermal, injection). High-dose IV PPI (adults: 80mg bolus + 8mg/h). ICU post-procedure. Second-look endoscopy in 24h. Surgical/IR standby. Children: use a children's formulary.

Ib — Active Oozing — Re-bleed ~55% 2

Forrest Ib: active oozing haemorrhage. Rebleeding ~55% without endoscopic therapy (active bleeding, Laine 1994).

→ Endoscopic therapy. IV PPI infusion. Close monitoring. Second-look scope at 24h if haemostasis achieved.

IIa — Visible Vessel — Re-bleed ~43% 3

Forrest IIa: non-bleeding visible vessel. Rebleeding ~43% without endoscopic therapy.

→ Endoscopic therapy required. IV PPI (adults: 80mg bolus + 8mg/h infusion × 72h). Admit. Monitor closely. Children: use a children's formulary.

IIb — Adherent Clot — Re-bleed ~22% 4

Forrest IIb: adherent clot. Rebleeding ~22% without endoscopic therapy.

→ Attempt clot removal and treat underlying lesion. IV PPI. Admit for observation.

IIc — Flat Pigmented Spot — Re-bleed ~10% 5

Forrest IIc: flat pigmented (haematin) spot. Rebleeding ~10%.

→ No endoscopic therapy required. Oral PPI. Discharge in 24–48h if stable. Oral diet resumed.

III — Clean Base — Re-bleed ~5% 6

Forrest III: clean ulcer base. Rebleeding ~5%.

→ No endoscopic therapy needed. Oral PPI. Early discharge if low risk on GBS/Rockall. Test for H. pylori. Review NSAIDs/anticoagulants.

Interpretation bands for the Forrest Classification. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.